Fidelity Investments’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-2,446,390
Closed -$9.59M 5775
2023
Q3
$9.59M Buy
2,446,390
+2,319,965
+1,835% +$9.09M ﹤0.01% 1838
2023
Q2
$411K Sell
126,425
-683,429
-84% -$2.22M ﹤0.01% 2720
2023
Q1
$2.93M Sell
809,854
-11,564
-1% -$41.8K ﹤0.01% 2263
2022
Q4
$26.4M Buy
821,418
+11,465
+1% +$369K ﹤0.01% 1503
2022
Q3
$33.9M Buy
809,953
+668
+0.1% +$27.9K ﹤0.01% 1401
2022
Q2
$34.2M Buy
809,285
+406,961
+101% +$17.2M ﹤0.01% 1427
2022
Q1
$27.3M Buy
402,324
+1,374
+0.3% +$93.2K ﹤0.01% 1647
2021
Q4
$48.7M Buy
400,950
+463
+0.1% +$56.2K ﹤0.01% 1431
2021
Q3
$56.4M Buy
400,487
+183
+0% +$25.8K ﹤0.01% 1362
2021
Q2
$110M Buy
400,304
+292
+0.1% +$80.2K 0.01% 1087
2021
Q1
$85.6M Buy
400,012
+59,844
+18% +$12.8M 0.01% 1137
2020
Q4
$82.3M Buy
340,168
+90,119
+36% +$21.8M 0.01% 1120
2020
Q3
$26.4M Buy
250,049
+22,488
+10% +$2.37M ﹤0.01% 1450
2020
Q2
$22.3M Buy
227,561
+66,518
+41% +$6.52M ﹤0.01% 1505
2020
Q1
$12.1M Sell
161,043
-1,078
-0.7% -$81K ﹤0.01% 1633
2019
Q4
$13.2M Sell
162,121
-3,377
-2% -$274K ﹤0.01% 1748
2019
Q3
$20.2M Sell
165,498
-2,885
-2% -$352K ﹤0.01% 1571
2019
Q2
$30.2M Buy
168,383
+2,128
+1% +$382K ﹤0.01% 1447
2019
Q1
$26.6M Buy
166,255
+955
+0.6% +$153K ﹤0.01% 1462
2018
Q4
$43M Buy
165,300
+2,055
+1% +$535K 0.01% 1210
2018
Q3
$38.6M Sell
163,245
-2,310
-1% -$546K ﹤0.01% 1394
2018
Q2
$36.8M Buy
+165,555
New +$36.8M ﹤0.01% 1430